{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:57:53Z","timestamp":1792173473878,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02910-x","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:03:24Z","timestamp":1724403804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antipsoriatic Effect of Silymarin NLCs Based Gel: In Vitro and In Vivo Activity"],"prefix":"10.1208","volume":"25","author":[{"given":"Faijmahmad","family":"Momin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kevlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-7104","authenticated-orcid":false,"given":"Shreeraj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"issue":"4","key":"2910_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/2229-5178.209622","volume":"8","author":"R Torsekar","year":"2017","unstructured":"Torsekar R, Gautam M. Topical therapies in psoriasis. Indian Dermatol Online J. 2017;8(4):235.","journal-title":"Indian Dermatol Online J"},{"issue":"6","key":"2910_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00059-005-2730-5","volume":"30","author":"B Maisch","year":"2005","unstructured":"Maisch B, Richter A, Sandm\u00f6ller A, Portig I, Pankuweit S. Inflammatory dilated cardiomyopathy (DCMI). Herz. 2005;30(6):535\u201344.","journal-title":"Herz"},{"issue":"3","key":"2910_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.15249","volume":"176","author":"J Yan","year":"2017","unstructured":"Yan J. Identifying biomarkers in human psoriasis: revealed by a systems metabolomics approach. Br J Dermatol. 2017;176(3):555\u20137.","journal-title":"Br J Dermatol"},{"key":"2910_CR4","first-page":"369","volume":"28","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. The BMJ. 2020;28:369.","journal-title":"The BMJ"},{"key":"2910_CR5","doi-asserted-by":"publisher","unstructured":"Liu J, Mooney H, Hull V, Davis SJ, Gaskell J, Hertel T, et al. Systems integration for global sustainability. Science (1979). 2015;347(6225). https:\/\/doi.org\/10.1126\/science.1258832","DOI":"10.1126\/science.1258832"},{"issue":"6","key":"2910_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/ijd.12870","volume":"54","author":"F Lacarrubba","year":"2015","unstructured":"Lacarrubba F, Pellacani G, Gurgone S, Verz\u00ec AE, Micali G. Advances in non-invasive techniques as aids to the diagnosis and monitoring of therapeutic response in plaque psoriasis: A review. Int J Dermatol. 2015;54(6):626\u201334.","journal-title":"Int J Dermatol"},{"key":"2910_CR7","doi-asserted-by":"crossref","unstructured":"Patel R, Patel S, Momin I, Shah S. The Evolving Landscape of Colonoscopy: Recent Developments and Complication Management. Colonoscopy - Diagnostic and Therapeutic Advances [Internet]. 2024 [cited 2024 Mar 28]; Available from: undefined\/chapters\/1160312","DOI":"10.5772\/intechopen.1003894"},{"issue":"68","key":"2910_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brat.2015.02.004","volume":"1","author":"AG Harvey","year":"2015","unstructured":"Harvey AG, Gumport NB. Evidence-based psychological treatments for mental disorders: Modifiable barriers to access and possible solutions. Behav Res Ther. 2015;1(68):1\u201312.","journal-title":"Behav Res Ther"},{"issue":"1","key":"2910_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1208\/s12249-021-02204-6","volume":"23","author":"R Obaidat","year":"2022","unstructured":"Obaidat R, Shameh AA, Aljarrah M, Hamed R. Preparation and Evaluation of Polyvinylpyrrolidone Electrospun Nanofiber Patches of Pioglitazone for the Treatment of Atopic Dermatitis. AAPS PharmSciTech. 2022;23(1):51.","journal-title":"AAPS PharmSciTech"},{"key":"2910_CR10","doi-asserted-by":"crossref","unstructured":"shah S, Patel R, Patel G. Nanocomposite hydrogels: an optimistic insight towards the treatments of ocular disorders. Recent Pat Nanotechnol [Internet]. 2023 [cited 2023 Aug 24];17. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37519202.","DOI":"10.2174\/1872210517666230731102130"},{"key":"2910_CR11","doi-asserted-by":"crossref","unstructured":"Of D, Accurate AN, Spectroscopic U V, For M, In T, Buffers V. Short communications development of an accurate uv spectroscopic method for tinidazole in vaginal buffers. 2024;61(May):64\u20137.","DOI":"10.53879\/id.61.05.14405"},{"key":"2910_CR12","doi-asserted-by":"publisher","unstructured":"Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria. Front Immunol. 2019;10(MAR). https:\/\/doi.org\/10.3389\/fimmu.2019.00627","DOI":"10.3389\/fimmu.2019.00627"},{"issue":"4","key":"2910_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020;181(4):914-921.e10.","journal-title":"Cell"},{"key":"2910_CR14","doi-asserted-by":"crossref","unstructured":"Yuan M, Wu NC, Zhu X, Lee CCD, So RTY, Lv H, et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science (1979). 2020;368(6491):630\u20133.","DOI":"10.1126\/science.abb7269"},{"key":"2910_CR15","doi-asserted-by":"publisher","unstructured":"Di Costanzo A, Angelico R. Formulation strategies for enhancing the bioavailability of silymarin: The state of the art. Molecules. 2019;24(11). https:\/\/doi.org\/10.3390\/molecules24112155","DOI":"10.3390\/molecules24112155"},{"issue":"3","key":"2910_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/1872210516666220628150447","volume":"17","author":"R Patel","year":"2022","unstructured":"Patel R, Yadav BK, Patel G. Progresses in Nano-Enabled Platforms for the Treatment of Vaginal Disorders. Recent Pat Nanotechnol. 2022;17(3):208\u201327.","journal-title":"Recent Pat Nanotechnol"},{"key":"2910_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-023-05804-4","volume":"25","author":"S Shah","year":"2023","unstructured":"Shah S, Patel AA, Prajapati BG, Alexander A, Pandya V, Trivedi N, et al. Multifaceted nanolipidic carriers: a modish stratagem accentuating nose-to-brain drug delivery. Journal of Nanoparticle Research Springer. 2023;25:1\u201334. https:\/\/doi.org\/10.1007\/s11051-023-05804-4. Springer.","journal-title":"Journal of Nanoparticle Research. Springer."},{"key":"2910_CR18","doi-asserted-by":"crossref","unstructured":"Patel RJ, Pandey P, Patel AA, Prajapati BG, Alexander A, Pandya V, et al. Ordered mesoporous silica nanocarriers: An innovative paradigm and a promising therapeutic efficient carrier for delivery of drugs. J Drug Deliv Sci Technol. 2023;82:104306.\u00a0Elsevier.","DOI":"10.1016\/j.jddst.2023.104306"},{"key":"2910_CR19","doi-asserted-by":"publisher","unstructured":"shah S, Patel R, Patel G. Nanocomposite hydrogels: an optimistic insight towards the treatments of ocular disorders. Recent Pat Nanotechnol. 2023;17. https:\/\/doi.org\/10.2174\/1872210517666230731102130","DOI":"10.2174\/1872210517666230731102130"},{"issue":"5","key":"2910_CR20","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s12035-020-01889-3","volume":"57","author":"AM Martins","year":"2020","unstructured":"Martins AM, Ascenso A, Ribeiro HM, Marto J. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs. Mol Neurobiol. 2020;57(5):2391\u2013419.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"2910_CR21","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","volume":"25","author":"VK Rapalli","year":"2020","unstructured":"Rapalli VK, Waghule T, Gorantla S, Dubey SK, Saha RN, Singhvi G. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discov Today. 2020;25(12):2212\u201326.","journal-title":"Drug Discov Today"},{"issue":"8","key":"2910_CR22","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1208\/s12249-018-1196-8","volume":"19","author":"DW Osborne","year":"2018","unstructured":"Osborne DW, Musakhanian J. Skin Penetration and Permeation Properties of Transcutol\u00ae\u2014Neat or Diluted Mixtures. AAPS PharmSciTech. 2018;19(8):3512\u201333.","journal-title":"AAPS PharmSciTech"},{"issue":"15","key":"2910_CR23","doi-asserted-by":"publisher","first-page":"18128","DOI":"10.1021\/acsami.1c03422","volume":"13","author":"AD Permana","year":"2021","unstructured":"Permana AD, Utomo E, Pratama MR, Amir MN, Anjani QK, Mardikasari SA, et al. Bioadhesive-Thermosensitive in Situ Vaginal Gel of the Gel Flake-Solid Dispersion of Itraconazole for Enhanced Antifungal Activity in the Treatment of Vaginal Candidiasis. ACS Appl Mater Interfaces. 2021;13(15):18128\u201341.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"2910_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2217\/nnm-2018-0235","volume":"14","author":"B Iqbal","year":"2019","unstructured":"Iqbal B, Ali J, Ganguli M, Mishra S, Baboota S. Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer. Nanomedicine. 2019;14(9):1077\u201393.","journal-title":"Nanomedicine"},{"issue":"26","key":"2910_CR25","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2217\/nnm-2020-0277","volume":"15","author":"B Mangla","year":"2020","unstructured":"Mangla B, Neupane YR, Singh A, Kumar P, Shafi S, Kohli K. Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: Ex vivo, in vivo and toxicity studies. Nanomedicine. 2020;15(26):2563\u201383.","journal-title":"Nanomedicine"},{"issue":"4","key":"2910_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.18231\/j.ctppc.2021.014","volume":"3","author":"R Hirlekar","year":"2021","unstructured":"Hirlekar R, Patil E, Bhairy S. Solid nanostructured lipid carriers loaded with silymarin for oral delivery: Formulation development and evaluation. Curr Trends iPharm Pharm Chem. 2021;3(4):56\u201367.","journal-title":"Curr Trends iPharm Pharm Chem"},{"issue":"5","key":"2910_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/03639045.2019.1576722","volume":"45","author":"P Sathe","year":"2019","unstructured":"Sathe P, Saka R, Kommineni N, Raza K, Khan W. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev Ind Pharm. 2019;45(5):826\u201338.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"2910_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.foodchem.2013.02.080","volume":"141","author":"A Hejri","year":"2013","unstructured":"Hejri A, Khosravi A, Gharanjig K, Hejazi M. Optimisation of the formulation of \u03b2-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Food Chem. 2013;141(1):117\u201323.","journal-title":"Food Chem"},{"key":"2910_CR29","doi-asserted-by":"crossref","unstructured":"Iqbal B, Ali J, Ganguli M, Mishra S, Baboota S. Silymarin-Loaded Nanostructured Lipid Carrier Gel for The Treatment of Skin Cancer. Nanomedicine [Internet]. 2019 [cited 2024 Jun 26];14(9):1077\u201393. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.2217\/nnm-2018-0235.","DOI":"10.2217\/nnm-2018-0235"},{"key":"2910_CR30","unstructured":"Tej K, Mouin A, Gowda DV, Anjali, Karunakar G, Patel N, et al. Nano structured lipid carrier based drug delivery system Gastro RDDS-Review View project Pectin-HPMC mesalamine tablets View project. J Chem Res. 2016;8(2):627\u201343."},{"key":"2910_CR31","doi-asserted-by":"publisher","unstructured":"Daubert CR, Farkas BE. Viscosity Measurement Using a Brookfield Viscometer. 2010;165\u20139. \nhttps:\/\/doi.org\/10.1007\/978-1-4419-1463-7_20","DOI":"10.1007\/978-1-4419-1463-7_20"},{"key":"2910_CR32","unstructured":"Patel G, Patel P, Sonara Z, Patel R, Pharm ( M. Fabrication and Optimization of 3D Printed Insert Coated With Rate Controlling Membrane in the Treatment of Recurrent Vaginal Candidiasis Via Vaginal Route. [cited 2023 Aug 24]; Available from: \nhttps:\/\/ssrn.com\/abstract=4514316."},{"issue":"255","key":"2910_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molliq.2018.01.141","volume":"1","author":"B Iqbal","year":"2018","unstructured":"Iqbal B, Ali J, Baboota S. Silymarin loaded nanostructured lipid carrier: From design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement. J Mol Liq. 2018;1(255):513\u201329.","journal-title":"J Mol Liq"},{"issue":"3","key":"2910_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1166\/jnn.2012.5173","volume":"12","author":"WC Hsu","year":"2012","unstructured":"Hsu WC, Ng LT, Wu TH, Lin LT, Yen FL, Lin CC. Characteristics and antioxidant activities of silymarin nanoparticles. J Nanosci Nanotechnol. 2012;12(3):2022\u20137.","journal-title":"J Nanosci Nanotechnol"},{"issue":"1\u20132","key":"2910_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijpharm.2015.02.070","volume":"485","author":"S Chaudhary","year":"2015","unstructured":"Chaudhary S, Garg T, Murthy RSR, Rath G, Goyal AK. Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway. Int J Pharm. 2015;485(1\u20132):108\u201321.","journal-title":"Int J Pharm"},{"issue":"88","key":"2910_CR36","doi-asserted-by":"publisher","first-page":"84965","DOI":"10.1039\/C6RA20231D","volume":"6","author":"P Singh","year":"2016","unstructured":"Singh P, Arya M, Kanoujia J, Singh M, Gupta KP, Saraf SA. Design of topical nanostructured lipid carrier of silymarin and its effect on 7,12-dimethylbenz[a] anthracene (DMBA) induced cellular differentiation in mouse skin. RSC Adv. 2016;6(88):84965\u201377.","journal-title":"RSC Adv"},{"issue":"7","key":"2910_CR37","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/jps.23146","volume":"101","author":"D Psimadas","year":"2012","unstructured":"Psimadas D, Georgoulias P, Valotassiou V, Loudos G. Molecular Nanomedicine Towards Cancer. J Pharm Sci. 2012;101(7):2271\u201380.","journal-title":"J Pharm Sci."},{"issue":"3","key":"2910_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/molecules21030265","volume":"21","author":"Y Ma","year":"2016","unstructured":"Ma Y, He S, Ma X, Hong T, Li Z, Park K, et al. Silymarin-loaded nanoparticles based on stearic acid-modified bletilla striata polysaccharide for hepatic targeting. Molecules. 2016;21(3):265.","journal-title":"Molecules"},{"issue":"1\u20132","key":"2910_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijpharm.2013.12.006","volume":"461","author":"LM Negi","year":"2014","unstructured":"Negi LM, Jaggi M, Talegaonkar S. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int J Pharm. 2014;461(1\u20132):403\u201310.","journal-title":"Int J Pharm"},{"issue":"84","key":"2910_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104552","volume":"1","author":"R Patel","year":"2023","unstructured":"Patel R, Shah R, Patel A, Hadiya K, Parmar J, Patel G. Off-Label use of Raloxifene hydrochloride in uterine fibroids: A novel insert-based formulation approach and IN-VIVO preclinical evaluation. J Drug Deliv Sci Technol. 2023;1(84): 104552.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"10","key":"2910_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/00914037.2023.2222334","volume":"73","author":"R Patel","year":"2024","unstructured":"Patel R, Shah U, Patel G. Optimization of poly(\u0395-caprolactone) based biodegradable in situ porous drug-eluting insert of BCS class II\/IV drug for targeted application. Int J Polym Mater Polym Biomater. 2024;73(10):885\u201396.","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"6","key":"2910_CR42","first-page":"571","volume":"11","author":"E Lakhe","year":"2021","unstructured":"Lakhe E. In -Vitro Assessment Of Anti-Inflammatory Activity Of Ethanolic Extract Of Fenugreek Seeds And Demonstration Of Effectiveness In Animal Models (In- Vivo) Through Characterization Of Gel Formulation Containing The Extract. Int J Sci Res Publ (IJSRP). 2021;11(6):571\u201385.","journal-title":"Int J Sci Res Publ (IJSRP)"},{"issue":"84","key":"2910_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104552","volume":"1","author":"R Patel","year":"2023","unstructured":"Patel R, Shah R, Patel A, Hadiya K, Parmar J, Patel G. Off-Label use of Raloxifene hydrochloride in uterine fibroids: A novel insert-based formulation approach and IN-VIVO preclinical evaluation. J Drug Deliv Sci Technol. 2023;1(84): 104552.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2910_CR44","unstructured":"View of Graphene Conjugated Usnic Acid Nano-Formulation For The Treatment Of Topical Fungal Infection [Internet]. [cited 2023 Sep 1]. Available from: \nhttps:\/\/journals.innovareacademics.in\/index.php\/ijpps\/article\/view\/34724\/22420."},{"key":"2910_CR45","doi-asserted-by":"publisher","unstructured":"Kirsten N, Rustenbach S, von Kiedrowski R, Sorbe C, Reich K, Augustin M. Which PASI outcome is most relevant to the patients in real-world care? Life. 2021;11(11). https:\/\/doi.org\/10.3390\/life11111151","DOI":"10.3390\/life11111151"},{"issue":"20","key":"2910_CR46","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1089\/neu.2021.0197","volume":"38","author":"J Tas","year":"2021","unstructured":"Tas J, Beqiri E, Van Kaam RC, Czosnyka M, Donnelly J, Haeren RH, et al. Targeting Autoregulation-Guided Cerebral Perfusion Pressure after Traumatic Brain Injury (COGiTATE): A Feasibility Randomized Controlled Clinical Trial. J Neurotrauma. 2021;38(20):2790\u2013800.","journal-title":"J Neurotrauma"},{"issue":"2","key":"2910_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2478\/v10007-010-0020-0","volume":"60","author":"Y Bachhav","year":"2010","unstructured":"Bachhav Y, Patravale V. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation. Acta Pharm. 2010;60(2):153\u201363.","journal-title":"Acta Pharm"},{"key":"2910_CR48","doi-asserted-by":"publisher","unstructured":"Jitta SR, Bhaskaran NA, Salwa, Kumar L. Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations. AAPS PharmSciTech. 2022;23(4). https:\/\/doi.org\/10.1208\/s12249-022-02240-w","DOI":"10.1208\/s12249-022-02240-w"},{"issue":"7","key":"2910_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1208\/s12249-022-02381-y","volume":"23","author":"K Rajpoot","year":"2022","unstructured":"Rajpoot K, Prajapati SK, Malaiya A, Jain R, Jain A. Meropenem-Loaded Nanostructured Lipid Carriers For Skin and Soft Tissue Infection Caused by Staphylococcus aureus: Formulation, Design, and Evaluation. AAPS PharmSciTech. 2022;23(7):241.","journal-title":"AAPS PharmSciTech"},{"key":"2910_CR50","doi-asserted-by":"publisher","unstructured":"Tietje C, Brouder A. Handbook of transnational economic governance regimes. Handbook of Transnational Economic Governance Regimes. 2009;1\u20131081. https:\/\/doi.org\/10.1163\/ej.9789004163300.i-1081","DOI":"10.1163\/ej.9789004163300.i-1081"},{"key":"2910_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.22159\/ijpps.2020v12i5.34724","volume":"24","author":"NK Dubey","year":"2020","unstructured":"Dubey NK, Mishra SB, Mukerjee A, Singh A. Graphene Conjugated Usnic Acid Nano-Formulation for the Treatment of Topical Fungal Infection. Int J Pharm Pharm Sci. 2020;24:47\u201353.","journal-title":"Int J Pharm Pharm Sci"},{"key":"2910_CR52","doi-asserted-by":"publisher","unstructured":"Ritesh, Chaurasia H, Singh R. Design, optimization, characterization of dapagliflozin loaded nlc using box-behnken design. Int J Health Sci (Qassim). 2022;26;7690\u2013711. https:\/\/doi.org\/10.53730\/ijhs.v6nS3.7932","DOI":"10.53730\/ijhs.v6nS3.7932"},{"key":"2910_CR53","doi-asserted-by":"publisher","unstructured":"Luki\u0107 M, Panteli\u0107 I, Savi\u0107 SD. Towards optimal ph of the skin and topical formulations: From the current state of the art to tailored products. Cosmetics. 2021;8(3). https:\/\/doi.org\/10.3390\/cosmetics8030069","DOI":"10.3390\/cosmetics8030069"},{"issue":"12","key":"2910_CR54","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41592-021-01319-9","volume":"18","author":"E Li","year":"2021","unstructured":"Li E, Guo J, Oh SJ, Luo Y, Oliveros HC, Du W, et al. Anterograde transneuronal tracing and genetic control with engineered yellow fever vaccine YFV-17D. Nat Methods. 2021;18(12):1542\u201351.","journal-title":"Nat Methods"},{"issue":"9","key":"2910_CR55","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/jmv.25832","volume":"92","author":"M Hussain","year":"2020","unstructured":"Hussain M, Jabeen N, Raza F, Shabbir S, Baig AA, Amanullah A, et al. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J Med Virol. 2020;92(9):1580\u20136.","journal-title":"J Med Virol"},{"issue":"109","key":"2910_CR56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tifs.2021.01.038","volume":"1","author":"G Huang","year":"2021","unstructured":"Huang G, Chen F, Yang W, Huang H. Preparation, deproteinization and comparison of bioactive polysaccharides. Trends Food Sci Technol. 2021;1(109):564\u20138.","journal-title":"Trends Food Sci Technol"},{"key":"2910_CR57","first-page":"163","volume":"12","author":"SK Manna","year":"1999","unstructured":"Manna SK. Silymarin Suppresses TNF-Induced Activation of NF-. Am Assoc Immunologists. 1999;12:163.","journal-title":"Am Assoc Immunologists."},{"key":"2910_CR58","doi-asserted-by":"crossref","unstructured":"K\u00f5ks S, Kingo K, Vasar E, Silm H. Psoriasis. Cytokine Gene Polymorphisms in Multifactorial Conditions. 2006;352(18):321\u201335.","DOI":"10.1201\/9781420005325.ch22"},{"issue":"1","key":"2910_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.0022-202x.2001.01642.x","volume":"118","author":"K Reich","year":"2002","unstructured":"Reich K, M\u00f6ssner R, K\u00f6nig IR, Westphal G, Ziegler A, Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-\u03b1 and interleukin-1\u03b2 are associated with different subtypes of psoriasis characterized by early and late disease onset. J Investig Dermatol. 2002;118(1):155\u201363.","journal-title":"J Investig Dermatol"},{"issue":"7","key":"2910_CR60","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.burns.2006.10.407","volume":"33","author":"HZ Toklu","year":"2007","unstructured":"Toklu HZ, Tunali-Akbay T, Erkanli G, Y\u00fcksel M, Ercan F, \u015eener G. Silymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injury. Burns. 2007;33(7):908\u201316.","journal-title":"Burns"},{"issue":"4","key":"2910_CR61","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1098-2744(199912)26:4<321::AID-MC11>3.0.CO;2-9","volume":"26","author":"J Zhao","year":"1999","unstructured":"Zhao J, Sharma Y, Agarwal R. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1\u03b1 expression in SENCAR mouse epidermis: Implication. Mol Carcinog. 1999;26(4):321\u201333.","journal-title":"Mol Carcinog"},{"issue":"16","key":"2910_CR62","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","volume":"86","author":"RM Grossman","year":"1989","unstructured":"Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, et al. Interleukin 6 is expressed in high levels of psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A. 1989;86(16):6367\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2910_CR63","doi-asserted-by":"publisher","unstructured":"Jur\u00e1\u0148ov\u00e1 J, Aury-Landas J, Boumediene K, Baug\u00e9 C, Biedermann D, Ulrichov\u00e1 J, et al. Modulation of skin inflammatory response by active components of silymarin. Molecules. 2019;24(1). https:\/\/doi.org\/10.3390\/molecules24010123","DOI":"10.3390\/molecules24010123"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02910-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02910-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02910-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:03:34Z","timestamp":1729695814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02910-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["2910"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02910-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"All experimental procedures and animal handling were performed following the ethical approval of the Institutional Animal Ethics Committee (IAEC) of L. J. Institute of Pharmacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}],"article-number":"195"}}